FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.

By
mdspire news news staff
January 4, 2026
2 min

Contact Lens Spectrum

Objective:

To announce the FDA clearance of the first daily disposable soft contact lens for presbyopia using extended depth of focus technology.

Approach:

Key Findings:

Deseyne offers a depth of focus comparable to FDA-approved EDOF intraocular lenses.
Clinically meaningful improvements in near and intermediate vision have been reported.
The lens is manufactured from vifilcon C hydrogel and includes components for hydration and comfort.

Interpretation:

The introduction of Deseyne represents a significant advancement in non-surgical options for managing presbyopia, potentially improving patient quality of life.

Limitations:

The article does not provide specific clinical trial data or outcomes from US-based studies.
Long-term effects and performance in diverse populations are yet to be established.